REPLICor is developing a broad spectrum antiviral drug, which has
the broadest spectrum of activity in vitro ever reported for a
single chemical entity and has proved to have a devastating action
on the herpes viruses, influenza and...
Croatian pharmaceutical company Pliva has forged another
partnership in the generic biopharmaceutical sector, linking up
with US firm Barr Laboratories to develop a generic version of
Amgen's white blood cell stimulator Neupogen...
Chemineer has launched a new mixer, called the Clean Sweep, which
features a new type of mixing action claimed to prevent
contamination and eliminate particle shedding from mechanical seals
or magnetic drive in-tank bearings.
In response to industry and customer demand, Elsevier is to build
an electronic notebook (ELN) designed for the life sciences
industry and which will significantly reduce cycle time in
biopharmaceutical R&D, writes Wai Lang Chu.
Ireland's largest home grown pharmaceutical company, Elan Holdings,
could be split up into two separate units, one focussing on
biotechnology and the other on manufacturing and drug delivery,
according to UK news reports.
UK company Atomising Systems Ltd has completed construction of a
cleanroom facility at its plant in Sheffeld, UK, that will be used
to produce a delivery vehicle used in Brachysil, a candidate drug
for liver cancer.
Beckman Coulter introduces a new flow cytometry system that is
aimed at the non-core lab, claiming the system's affordability and
small footprint makes it ideal for cellular analysis in research
and drug discovery applications
Rhodia is facing two separate investigations for alleged accounting
irregularities as well as insider trading, just as the financial
difficulties afflicting the French chemicals group have started to